Minimal Residual Disease in Multiple Myeloma: Current Landscape and Future Applications With Immunotherapeutic Approaches

Minimal Residual Disease in Multiple Myeloma: Current Landscape and Future Applications With Immunotherapeutic Approaches

The basic principle that deeper therapeutic responses lead to better clinical outcomes in cancer has emerged technologies capable of detecting rare residual tumor cells. The need for ultra-sensitive approaches for minimal residual disease (MRD) detection is particularly evident in Multiple Myeloma (...

Full description

Bibliographic Details
Main Authors: Ioannis V. Kostopoulos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Ourania E. Tsitsilonis, Evangelos Terpos
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Oncology
Subjects:
multiple myeloma
minimal residual disease
prognostic factor
primary endpoint
therapeutic intervention
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00860/full

Similar Items

Similar Items